Facebook bans far-right Proud Boys after violent clash
Extremist group and its founder, Gavin McInnis, to lose main recruiting tool
All Posts in "Markets"
Cannabis stocks mixed after Coca-Cola says it has no plans for sector
News dampened excitement about beverages companies bringing capital and marketing clout to growing sector
Stocks rally to close higher after Monday’s big reversal
Dow component Coca-Cola gains after topping earnings expectations; Pfizer disappoints on results
Oil prices decline as demand worries outweigh Iran supply challenges
November natural-gas futures end flat as contract expires
Dubious pot stock IGC has trading suspended, shares to be delisted
NYSE American takes aim at company after it claimed to be developing cannabis-derived drinks and sent shares soaring
How much each U.S. president has contributed to the national debt
Donald Trump claimed on the campaign trail that, as president, he would completely eliminate the then–$19 trillion in national debt. Let’s just say he’s not exactly on track.
Walmart to use roving checkout scanners to streamline holiday shopping
Retail giant touts new digital store maps, upgraded website
Most Americans say their finances have not improved since the 2016 election
How you feel about the economy often depends on whether you’re a Democrat or a Republican
Facebook earnings: Will advertisers stick with the social network?
After forecast hacked $120 billion from Facebook’s market cap, company prepares to report the actual results
Snap stock falls after user base shrinks again but new ad formats gain steam
Company introduced two new ad products for the holidays
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis